FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 354:75-77 January 5, 2006 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Ruiz-Palacios, G. M. Related Article by Vesikari, T. PubMed Citation

Rotavirus disease kills approximately half a million children annually in developing countries and accounts for one third of hospitalizations for diarrhea worldwide.¹ In 1999, global efforts to control the tremendous health burden of gastroenteritis suffered an abrupt and unanticipated setback. The first licensed rotavirus vaccine (RotaShield) was withdrawn from the U.S. market less than a year after its introduction because it was associated with an uncommon but potentially life-threatening adverse event, intussusception, at an estimated rate of 1 incident per 10,000 vaccine recipients.²

(Figure)

View larger version (101K): [in this window] [in a new window]   Figure 1. Negative-Stain Electron Micrograph of Rotavirus A. The virus is 70 to 75 nm in . . . [Full Text of this Article]

 

Source Information

From the Centers for Disease Control and Prevention, Atlanta.

Related Letters:

Rotavirus Vaccines
Molinaro G. A., Lee D. A., Lee P.-I., Simonsen L., Taylor R. J., Kapikian A. Z., Ruiz L. P. Jr., O'Ryan M., Ruiz-Palacios G. M., Clemens R., Vesikari T., DiNubile M. J., Heaton P. M., Glass R. I., Parashar U. D.
Extract | Full Text | PDF  
N Engl J Med 2006; 354:1747-1751, Apr 20, 2006. Correspondence

This article has been cited by other articles:

• Seo, N.-S., Zeng, C. Q.-Y., Hyser, J. M., Utama, B., Crawford, S. E., Kim, K. J., Hook, M., Estes, M. K. (2008). Inaugural Article: Integrins {alpha}1{beta}1 and {alpha}2{beta}1 are receptors for the rotavirus enterotoxin. Proc. Natl. Acad. Sci. USA 105: 8811-8818 [Abstract] [Full Text]  
• Rahman, M., Matthijnssens, J., Yang, X., Delbeke, T., Arijs, I., Taniguchi, K., Iturriza-Gomara, M., Iftekharuddin, N., Azim, T., Van Ranst, M. (2007). Evolutionary History and Global Spread of the Emerging G12 Human Rotaviruses. J. Virol. 81: 2382-2390 [Abstract] [Full Text]  
• Snyder, J. (2007). Rotavirus Vaccine: Who Will Benefit?. AAP Grand Rounds 17: 5-6 [Full Text]  
• Bojsen, A., Buesa, J., Montava, R., Kvistgaard, A. S., Kongsbak, M. B., Petersen, T. E., Heegaard, C. W., Rasmussen, J. T. (2007). Inhibitory Activities of Bovine Macromolecular Whey Proteins on Rotavirus Infections In Vitro and In Vivo. J DAIRY SCI 90: 66-74 [Abstract] [Full Text]  
• Kempe, A., Daley, M. F., Parashar, U. D., Crane, L. A., Beaty, B. L., Stokley, S., Barrow, J., Babbel, C., Dickinson, L. M., Widdowson, M.-A., Alexander, J. P., Berman, S. (2007). Will Pediatricians Adopt the New Rotavirus Vaccine?. Pediatrics 119: 1-10 [Abstract] [Full Text]  
• (2006). Journal Watch. Arch. Dis. Child. 91: 449-450 [Full Text]  
• Molinaro, G. A., Lee, D. A., Lee, P.-I., Simonsen, L., Taylor, R. J., Kapikian, A. Z., Ruiz, L. P. Jr., O'Ryan, M., Ruiz-Palacios, G. M., Clemens, R., Vesikari, T., DiNubile, M. J., Heaton, P. M., Glass, R. I., Parashar, U. D. (2006). Rotavirus vaccines.. NEJM 354: 1747-1751 [Full Text]  
• (2006). Rotavirus Vaccines Are Coming Soon. JWatch Pediatrics 2006: 1-1 [Full Text]  
• (2006). Rotavirus Vaccines Are Coming Soon. JWatch General 2006: 1-1 [Full Text]